Cinnulin PF® May Protect Against Metabolic Syndrome

December 11, 2006

1 Min Read
Cinnulin PF® May Protect Against Metabolic Syndrome

SARASOTA, Fla.A proprietary cinnamon extract (Cinnulin PF®, from Integrity Nutraceuticals) may provide protective antioxidant effects in reducing oxidative stress associated with metabolic syndromeassociated with early signs of diabetes and cardiovascular disease. In the placebo-controlled, double blind study, 24 patients with impaired fasting glucose were given either 250 mg of Cinnulin PF or placebo, twice daily for two weeks. The Cinnulin PF group saw a significant increase ferric reducing ability of plasma (FRAP) and plasma SH (MDA)two measures that determine antioxidant activity. Additionally, the cinnamon group demonstrated a decrease in malondialdehyde (MDA), a factor in protecting heart health. No changes were observed in the placebo group. The results of Dr. Anne-Marie Rousels study are extremely positive, according to research collaborator, and U.S. Department of Agriculture cinnamon researcher, Richard A. Anderson, Ph.D. People with impaired insulin function are at higher risk of developing life-threatening chronic diseases, including diabetes and heart disease, the number one killer in the United States. This study tells us that the active compounds found in cinnamon extract may be helpful in reducing the risk of these diseases by providing cells protection from harmful oxidation. The study, presented at the 47th American College of Nutrition annual meeting in October, is the first demonstration of Cinnulin PFs effects on antioxidant status on humans.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like